The Beauty Health Company (NASDAQ:SKIN - Get Free Report) shares passed below its two hundred day moving average during trading on Monday. The stock has a two hundred day moving average of $15.94 and traded as low as $14.84. Beauty Health shares last traded at $15.05, with a volume of 73,146 shares.
Analysts Set New Price Targets
Several brokerages have recently weighed in on SKIN. Raymond James Financial set a $14.00 target price on Beauty Health in a report on Monday, November 9th. Canaccord Genuity Group set a $11.00 price target on Beauty Health and gave the company a "hold" rating in a report on Thursday, October 22nd. Jefferies Financial Group reiterated a "hold" rating and set a $11.00 price objective (up from $0.85) on shares of Beauty Health in a research report on Monday, October 19th. Weiss Ratings reiterated a "sell (e+)" rating on shares of Beauty Health in a research report on Wednesday, October 21st. Finally, TD Cowen restated a "hold" rating and issued a $14.00 target price (up from $0.90) on shares of Beauty Health in a report on Monday, November 9th. One analyst has rated the stock with a Buy rating, six have given a Hold rating and one has assigned a Sell rating to the company's stock. According to data from MarketBeat, Beauty Health currently has a consensus rating of "Hold" and an average target price of $16.67.
Read Our Latest Report on Beauty Health
Beauty Health Stock Performance
The firm's fifty day moving average is $12.58 and its 200-day moving average is $15.94. The company has a current ratio of 2.89, a quick ratio of 1.48 and a debt-to-equity ratio of 4.36. The stock has a market capitalization of $97.98 million, a PE ratio of -5.49 and a beta of 1.05.
Beauty Health (NASDAQ:SKIN - Get Free Report) last announced its earnings results on Thursday, November 5th. The company reported ($0.14) earnings per share for the quarter, topping the consensus estimate of ($1.33) by $1.19. Beauty Health had a negative net margin of 6.34% and a negative return on equity of 32.16%. The company had revenue of $69.17 million during the quarter, compared to analyst estimates of $67.97 million. As a group, research analysts anticipate that The Beauty Health Company will post -2.56 earnings per share for the current year.
Institutional Trading of Beauty Health
An institutional investor recently raised its stake in Beauty Health stock. Renaissance Technologies LLC grew its position in shares of The Beauty Health Company (NASDAQ:SKIN - Free Report) by 29.6% during the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 283,791 shares of the company's stock after buying an additional 64,900 shares during the period. Renaissance Technologies LLC owned about 0.22% of Beauty Health worth $253,000 as of its most recent SEC filing. 93.26% of the stock is owned by hedge funds and other institutional investors.
About Beauty Health
(
Get Free Report)
The Beauty Health Company develops and sells products and services for the beauty and skincare market. Its best-known brand, Hydrafacial, offers a facial treatment that uses specialized equipment and serums to cleanse, exfoliate and hydrate the skin. The company supplies Hydrafacial devices and related consumable products to professional providers, including spas, dermatology practices and other skincare businesses. It also offers skincare products associated with its treatments. Based in Long Beach, California, BeautyHealth serves customers through professional and consumer channels in markets around the world.
Read More
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Beauty Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Beauty Health wasn't on the list.
While Beauty Health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.